Ellipses Pharma on our unique approach to developing cancer medicines faster

Hear from our Chairman, Professor Sir Chris Evans, our CEO, Dr Rajan Jethwa and our Global Head of Drug Development, Professor Tobi Arkenau alongside other industry experts and get a look inside Ellipses to discover how our unique approach develops cancer medicines faster.

This feature is part of a Viewpoint docuseries committed to providing scientifically backed information on current affairs, such as healthcare. Learn more about the collaboration between Ellipses Pharma and Viewpoint here.